img

Global G-CSF and G-CSF Biosimilars Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global G-CSF and G-CSF Biosimilars Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimulate mobilization of haematopoietic stem cells for collection and transplantation.
G-CSF and G-CSF Biosimilars report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global G-CSF and G-CSF Biosimilars market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Human Growth Hormone and Erythropoietin are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for G-CSF and G-CSF Biosimilars industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, G-CSF and G-CSF Biosimilars key manufacturers include Pfizer, Novartis, Roche, Merck & Co., Sanofi, Johnson & Johnson, Gilead Science, GlaxoSmithKline and AbbVie, etc. Pfizer, Novartis, Roche are top 3 players and held % sales share in total in 2022.
G-CSF and G-CSF Biosimilars can be divided into Blood Disorders, Oncology Diseases, Chronic And Autoimmune Diseases and Growth Hormone Deficiencies, etc. Blood Disorders is the mainstream product in the market, accounting for % sales share globally in 2022.
G-CSF and G-CSF Biosimilars is widely used in various fields, such as Human Growth Hormone, Erythropoietin, Monoclonal Antibodies and Insulin, etc. Human Growth Hormone provides greatest supports to the G-CSF and G-CSF Biosimilars industry development. In 2022, global % sales of G-CSF and G-CSF Biosimilars went into Human Growth Hormone filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global G-CSF and G-CSF Biosimilars market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Novartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Segment by Type
Blood Disorders
Oncology Diseases
Chronic And Autoimmune Diseases
Growth Hormone Deficiencies

Segment by Application


Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the G-CSF and G-CSF Biosimilars market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of G-CSF and G-CSF Biosimilars, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the G-CSF and G-CSF Biosimilars industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of G-CSF and G-CSF Biosimilars in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, G-CSF and G-CSF Biosimilars introduction, etc. G-CSF and G-CSF Biosimilars Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of G-CSF and G-CSF Biosimilars market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 G-CSF and G-CSF Biosimilars Market Overview
1.1 G-CSF and G-CSF Biosimilars Product Overview
1.2 G-CSF and G-CSF Biosimilars Market Segment by Type
1.2.1 Blood Disorders
1.2.2 Oncology Diseases
1.2.3 Chronic And Autoimmune Diseases
1.2.4 Growth Hormone Deficiencies
1.3 Global G-CSF and G-CSF Biosimilars Market Size by Type
1.3.1 Global G-CSF and G-CSF Biosimilars Market Size Overview by Type (2024-2034)
1.3.2 Global G-CSF and G-CSF Biosimilars Historic Market Size Review by Type (2024-2024)
1.3.3 Global G-CSF and G-CSF Biosimilars Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America G-CSF and G-CSF Biosimilars Sales Breakdown by Type (2024-2024)
1.4.2 Europe G-CSF and G-CSF Biosimilars Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific G-CSF and G-CSF Biosimilars Sales Breakdown by Type (2024-2024)
1.4.4 Latin America G-CSF and G-CSF Biosimilars Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa G-CSF and G-CSF Biosimilars Sales Breakdown by Type (2024-2024)
2 Global G-CSF and G-CSF Biosimilars Market Competition by Company
2.1 Global Top Players by G-CSF and G-CSF Biosimilars Sales (2024-2024)
2.2 Global Top Players by G-CSF and G-CSF Biosimilars Revenue (2024-2024)
2.3 Global Top Players by G-CSF and G-CSF Biosimilars Price (2024-2024)
2.4 Global Top Manufacturers G-CSF and G-CSF Biosimilars Manufacturing Base Distribution, Sales Area, Product Type
2.5 G-CSF and G-CSF Biosimilars Market Competitive Situation and Trends
2.5.1 G-CSF and G-CSF Biosimilars Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by G-CSF and G-CSF Biosimilars Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in G-CSF and G-CSF Biosimilars as of 2022)
2.7 Date of Key Manufacturers Enter into G-CSF and G-CSF Biosimilars Market
2.8 Key Manufacturers G-CSF and G-CSF Biosimilars Product Offered
2.9 Mergers & Acquisitions, Expansion
3 G-CSF and G-CSF Biosimilars Status and Outlook by Region
3.1 Global G-CSF and G-CSF Biosimilars Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global G-CSF and G-CSF Biosimilars Historic Market Size by Region
3.2.1 Global G-CSF and G-CSF Biosimilars Sales in Volume by Region (2024-2024)
3.2.2 Global G-CSF and G-CSF Biosimilars Sales in Value by Region (2024-2024)
3.2.3 Global G-CSF and G-CSF Biosimilars Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global G-CSF and G-CSF Biosimilars Forecasted Market Size by Region
3.3.1 Global G-CSF and G-CSF Biosimilars Sales in Volume by Region (2024-2034)
3.3.2 Global G-CSF and G-CSF Biosimilars Sales in Value by Region (2024-2034)
3.3.3 Global G-CSF and G-CSF Biosimilars Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global G-CSF and G-CSF Biosimilars by Application
4.1 G-CSF and G-CSF Biosimilars Market Segment by Application
4.1.1 Human Growth Hormone
4.1.2 Erythropoietin
4.1.3 Monoclonal Antibodies
4.1.4 Insulin
4.1.5 Interferon
4.2 Global G-CSF and G-CSF Biosimilars Market Size by Application
4.2.1 Global G-CSF and G-CSF Biosimilars Market Size Overview by Application (2024-2034)
4.2.2 Global G-CSF and G-CSF Biosimilars Historic Market Size Review by Application (2024-2024)
4.2.3 Global G-CSF and G-CSF Biosimilars Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America G-CSF and G-CSF Biosimilars Sales Breakdown by Application (2024-2024)
4.3.2 Europe G-CSF and G-CSF Biosimilars Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific G-CSF and G-CSF Biosimilars Sales Breakdown by Application (2024-2024)
4.3.4 Latin America G-CSF and G-CSF Biosimilars Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa G-CSF and G-CSF Biosimilars Sales Breakdown by Application (2024-2024)
5 North America G-CSF and G-CSF Biosimilars by Country
5.1 North America G-CSF and G-CSF Biosimilars Historic Market Size by Country
5.1.1 North America G-CSF and G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America G-CSF and G-CSF Biosimilars Sales in Volume by Country (2024-2024)
5.1.3 North America G-CSF and G-CSF Biosimilars Sales in Value by Country (2024-2024)
5.2 North America G-CSF and G-CSF Biosimilars Forecasted Market Size by Country
5.2.1 North America G-CSF and G-CSF Biosimilars Sales in Volume by Country (2024-2034)
5.2.2 North America G-CSF and G-CSF Biosimilars Sales in Value by Country (2024-2034)
6 Europe G-CSF and G-CSF Biosimilars by Country
6.1 Europe G-CSF and G-CSF Biosimilars Historic Market Size by Country
6.1.1 Europe G-CSF and G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe G-CSF and G-CSF Biosimilars Sales in Volume by Country (2024-2024)
6.1.3 Europe G-CSF and G-CSF Biosimilars Sales in Value by Country (2024-2024)
6.2 Europe G-CSF and G-CSF Biosimilars Forecasted Market Size by Country
6.2.1 Europe G-CSF and G-CSF Biosimilars Sales in Volume by Country (2024-2034)
6.2.2 Europe G-CSF and G-CSF Biosimilars Sales in Value by Country (2024-2034)
7 Asia-Pacific G-CSF and G-CSF Biosimilars by Region
7.1 Asia-Pacific G-CSF and G-CSF Biosimilars Historic Market Size by Region
7.1.1 Asia-Pacific G-CSF and G-CSF Biosimilars Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific G-CSF and G-CSF Biosimilars Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific G-CSF and G-CSF Biosimilars Sales in Value by Region (2024-2024)
7.2 Asia-Pacific G-CSF and G-CSF Biosimilars Forecasted Market Size by Region
7.2.1 Asia-Pacific G-CSF and G-CSF Biosimilars Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific G-CSF and G-CSF Biosimilars Sales in Value by Region (2024-2034)
8 Latin America G-CSF and G-CSF Biosimilars by Country
8.1 Latin America G-CSF and G-CSF Biosimilars Historic Market Size by Country
8.1.1 Latin America G-CSF and G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America G-CSF and G-CSF Biosimilars Sales in Volume by Country (2024-2024)
8.1.3 Latin America G-CSF and G-CSF Biosimilars Sales in Value by Country (2024-2024)
8.2 Latin America G-CSF and G-CSF Biosimilars Forecasted Market Size by Country
8.2.1 Latin America G-CSF and G-CSF Biosimilars Sales in Volume by Country (2024-2034)
8.2.2 Latin America G-CSF and G-CSF Biosimilars Sales in Value by Country (2024-2034)
9 Middle East and Africa G-CSF and G-CSF Biosimilars by Country
9.1 Middle East and Africa G-CSF and G-CSF Biosimilars Historic Market Size by Country
9.1.1 Middle East and Africa G-CSF and G-CSF Biosimilars Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa G-CSF and G-CSF Biosimilars Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa G-CSF and G-CSF Biosimilars Sales in Value by Country (2024-2024)
9.2 Middle East and Africa G-CSF and G-CSF Biosimilars Forecasted Market Size by Country
9.2.1 Middle East and Africa G-CSF and G-CSF Biosimilars Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa G-CSF and G-CSF Biosimilars Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Pfizer G-CSF and G-CSF Biosimilars Products Offered
10.1.5 Pfizer Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Novartis G-CSF and G-CSF Biosimilars Products Offered
10.2.5 Novartis Recent Development
10.3 Roche
10.3.1 Roche Company Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Roche G-CSF and G-CSF Biosimilars Products Offered
10.3.5 Roche Recent Development
10.4 Merck & Co.
10.4.1 Merck & Co. Company Information
10.4.2 Merck & Co. Introduction and Business Overview
10.4.3 Merck & Co. G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Merck & Co. G-CSF and G-CSF Biosimilars Products Offered
10.4.5 Merck & Co. Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Sanofi G-CSF and G-CSF Biosimilars Products Offered
10.5.5 Sanofi Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Johnson & Johnson G-CSF and G-CSF Biosimilars Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 Gilead Science
10.7.1 Gilead Science Company Information
10.7.2 Gilead Science Introduction and Business Overview
10.7.3 Gilead Science G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Gilead Science G-CSF and G-CSF Biosimilars Products Offered
10.7.5 Gilead Science Recent Development
10.8 GlaxoSmithKline
10.8.1 GlaxoSmithKline Company Information
10.8.2 GlaxoSmithKline Introduction and Business Overview
10.8.3 GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2024-2024)
10.8.4 GlaxoSmithKline G-CSF and G-CSF Biosimilars Products Offered
10.8.5 GlaxoSmithKline Recent Development
10.9 AbbVie
10.9.1 AbbVie Company Information
10.9.2 AbbVie Introduction and Business Overview
10.9.3 AbbVie G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2024-2024)
10.9.4 AbbVie G-CSF and G-CSF Biosimilars Products Offered
10.9.5 AbbVie Recent Development
10.10 Amgen
10.10.1 Amgen Company Information
10.10.2 Amgen Introduction and Business Overview
10.10.3 Amgen G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Amgen G-CSF and G-CSF Biosimilars Products Offered
10.10.5 Amgen Recent Development
10.11 AstraZeneca
10.11.1 AstraZeneca Company Information
10.11.2 AstraZeneca Introduction and Business Overview
10.11.3 AstraZeneca G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2024-2024)
10.11.4 AstraZeneca G-CSF and G-CSF Biosimilars Products Offered
10.11.5 AstraZeneca Recent Development
10.12 Bayer
10.12.1 Bayer Company Information
10.12.2 Bayer Introduction and Business Overview
10.12.3 Bayer G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Bayer G-CSF and G-CSF Biosimilars Products Offered
10.12.5 Bayer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 G-CSF and G-CSF Biosimilars Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 G-CSF and G-CSF Biosimilars Industrial Chain Analysis
11.4 G-CSF and G-CSF Biosimilars Market Dynamics
11.4.1 G-CSF and G-CSF Biosimilars Industry Trends
11.4.2 G-CSF and G-CSF Biosimilars Market Drivers
11.4.3 G-CSF and G-CSF Biosimilars Market Challenges
11.4.4 G-CSF and G-CSF Biosimilars Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 G-CSF and G-CSF Biosimilars Distributors
12.3 G-CSF and G-CSF Biosimilars Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Blood Disorders
Table 2. Major Company of Oncology Diseases
Table 3. Major Company of Chronic And Autoimmune Diseases
Table 4. Major Company of Growth Hormone Deficiencies
Table 5. Global G-CSF and G-CSF Biosimilars Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global G-CSF and G-CSF Biosimilars Sales by Type (2024-2024) & (K Units)
Table 7. Global G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Type (2024-2024)
Table 8. Global G-CSF and G-CSF Biosimilars Sales by Type (2024-2024) & (US& Million)
Table 9. Global G-CSF and G-CSF Biosimilars Market Share in Value by Type (2024-2024)
Table 10. Global G-CSF and G-CSF Biosimilars Price by Type (2024-2024) & (USD/Unit)
Table 11. Global G-CSF and G-CSF Biosimilars Sales by Type (2024-2034) & (K Units)
Table 12. Global G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Type (2024-2034)
Table 13. Global G-CSF and G-CSF Biosimilars Sales by Type (2024-2034) & (US$ Million)
Table 14. Global G-CSF and G-CSF Biosimilars Sales Market Share in Value by Type (2024-2034)
Table 15. Global G-CSF and G-CSF Biosimilars Price by Type (2024-2034) & (USD/Unit)
Table 16. North America G-CSF and G-CSF Biosimilars Sales by Type (2024-2024) & (K Units)
Table 17. North America G-CSF and G-CSF Biosimilars Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe G-CSF and G-CSF Biosimilars Sales (K Units) by Type (2024-2024)
Table 19. Europe G-CSF and G-CSF Biosimilars Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific G-CSF and G-CSF Biosimilars Sales (K Units) by Type (2024-2024)
Table 21. Asia-Pacific G-CSF and G-CSF Biosimilars Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America G-CSF and G-CSF Biosimilars Sales (K Units) by Type (2024-2024)
Table 23. Latin America G-CSF and G-CSF Biosimilars Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa G-CSF and G-CSF Biosimilars Sales (K Units) by Type (2024-2024)
Table 25. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Type (2024-2024) & (US$ Million)
Table 26. Global G-CSF and G-CSF Biosimilars Sales by Company (2024-2024) & (K Units)
Table 27. Global G-CSF and G-CSF Biosimilars Sales Share by Company (2024-2024)
Table 28. Global G-CSF and G-CSF Biosimilars Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global G-CSF and G-CSF Biosimilars Revenue Share by Company (2024-2024)
Table 30. Global Market G-CSF and G-CSF Biosimilars Price by Company (2024-2024) & (USD/Unit)
Table 31. Global G-CSF and G-CSF Biosimilars Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global G-CSF and G-CSF Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in G-CSF and G-CSF Biosimilars as of 2022)
Table 34. Date of Key Manufacturers Enter into G-CSF and G-CSF Biosimilars Market
Table 35. Key Manufacturers G-CSF and G-CSF Biosimilars Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global G-CSF and G-CSF Biosimilars Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global G-CSF and G-CSF Biosimilars Sales by Region (2024-2024) & (K Units)
Table 39. Global G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Region (2024-2024)
Table 40. Global G-CSF and G-CSF Biosimilars Sales by Region (2024-2024) & (US$ Million)
Table 41. Global G-CSF and G-CSF Biosimilars Sales Market Share in Value by Region (2024-2024)
Table 42. Global G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 43. Global G-CSF and G-CSF Biosimilars Sales by Region (2024-2034) & (K Units)
Table 44. Global G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Region (2024-2034)
Table 45. Global G-CSF and G-CSF Biosimilars Sales by Region (2024-2034) & (US$ Million)
Table 46. Global G-CSF and G-CSF Biosimilars Sales Market Share in Value by Region (2024-2034)
Table 47. Global G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global G-CSF and G-CSF Biosimilars Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global G-CSF and G-CSF Biosimilars Sales by Application (2024-2024) & (K Units)
Table 50. Global G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Application (2024-2024)
Table 51. Global G-CSF and G-CSF Biosimilars Sales by Application (2024-2024) & (US$ Million)
Table 52. Global G-CSF and G-CSF Biosimilars Sales Market Share in Value by Application (2024-2024)
Table 53. Global G-CSF and G-CSF Biosimilars Price by Application (2024-2024) & (USD/Unit)
Table 54. Global G-CSF and G-CSF Biosimilars Sales by Application (2024-2034) & (K Units)
Table 55. Global G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Application (2024-2034)
Table 56. Global G-CSF and G-CSF Biosimilars Sales by Application (2024-2034) & (US$ Million)
Table 57. Global G-CSF and G-CSF Biosimilars Sales Market Share in Value by Application (2024-2034)
Table 58. Global G-CSF and G-CSF Biosimilars Price by Application (2024-2034) & (USD/Unit)
Table 59. North America G-CSF and G-CSF Biosimilars Sales by Application (2024-2024) (K Units)
Table 60. North America G-CSF and G-CSF Biosimilars Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe G-CSF and G-CSF Biosimilars Sales by Application (2024-2024) (K Units)
Table 62. Europe G-CSF and G-CSF Biosimilars Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific G-CSF and G-CSF Biosimilars Sales by Application (2024-2024) (K Units)
Table 64. Asia-Pacific G-CSF and G-CSF Biosimilars Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America G-CSF and G-CSF Biosimilars Sales by Application (2024-2024) (K Units)
Table 66. Latin America G-CSF and G-CSF Biosimilars Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Application (2024-2024) (K Units)
Table 68. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Application (2024-2024) & (US$ Million)
Table 69. North America G-CSF and G-CSF Biosimilars Sales by Country (2024-2024) & (K Units)
Table 70. North America G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Country (2024-2024)
Table 71. North America G-CSF and G-CSF Biosimilars Sales by Country (2024-2024) & (US$ Million)
Table 72. North America G-CSF and G-CSF Biosimilars Sales Market Share in Value by Country (2024-2024)
Table 73. North America G-CSF and G-CSF Biosimilars Sales by Country (2024-2034) & (K Units)
Table 74. North America G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Country (2024-2034)
Table 75. North America G-CSF and G-CSF Biosimilars Sales by Country (2024-2034) & (US$ Million)
Table 76. North America G-CSF and G-CSF Biosimilars Sales Market Share in Value by Country (2024-2034)
Table 77. Europe G-CSF and G-CSF Biosimilars Sales by Country (2024-2024) & (K Units)
Table 78. Europe G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe G-CSF and G-CSF Biosimilars Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe G-CSF and G-CSF Biosimilars Sales Market Share in Value by Country (2024-2024)
Table 81. Europe G-CSF and G-CSF Biosimilars Sales by Country (2024-2034) & (K Units)
Table 82. Europe G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe G-CSF and G-CSF Biosimilars Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe G-CSF and G-CSF Biosimilars Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific G-CSF and G-CSF Biosimilars Sales by Region (2024-2024) & (K Units)
Table 86. Asia-Pacific G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific G-CSF and G-CSF Biosimilars Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific G-CSF and G-CSF Biosimilars Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific G-CSF and G-CSF Biosimilars Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific G-CSF and G-CSF Biosimilars Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific G-CSF and G-CSF Biosimilars Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America G-CSF and G-CSF Biosimilars Sales by Country (2024-2024) & (K Units)
Table 94. Latin America G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America G-CSF and G-CSF Biosimilars Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America G-CSF and G-CSF Biosimilars Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America G-CSF and G-CSF Biosimilars Sales by Country (2024-2034) & (K Units)
Table 98. Latin America G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America G-CSF and G-CSF Biosimilars Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America G-CSF and G-CSF Biosimilars Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Country (2024-2024) & (K Units)
Table 102. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Market Share in Value by Country (2024-2034)
Table 109. Pfizer Company Information
Table 110. Pfizer Introduction and Business Overview
Table 111. Pfizer G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 112. Pfizer G-CSF and G-CSF Biosimilars Product
Table 113. Pfizer Recent Development
Table 114. Novartis Company Information
Table 115. Novartis Introduction and Business Overview
Table 116. Novartis G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 117. Novartis G-CSF and G-CSF Biosimilars Product
Table 118. Novartis Recent Development
Table 119. Roche Company Information
Table 120. Roche Introduction and Business Overview
Table 121. Roche G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 122. Roche G-CSF and G-CSF Biosimilars Product
Table 123. Roche Recent Development
Table 124. Merck & Co. Company Information
Table 125. Merck & Co. Introduction and Business Overview
Table 126. Merck & Co. G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 127. Merck & Co. G-CSF and G-CSF Biosimilars Product
Table 128. Merck & Co. Recent Development
Table 129. Sanofi Company Information
Table 130. Sanofi Introduction and Business Overview
Table 131. Sanofi G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 132. Sanofi G-CSF and G-CSF Biosimilars Product
Table 133. Sanofi Recent Development
Table 134. Johnson & Johnson Company Information
Table 135. Johnson & Johnson Introduction and Business Overview
Table 136. Johnson & Johnson G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 137. Johnson & Johnson G-CSF and G-CSF Biosimilars Product
Table 138. Johnson & Johnson Recent Development
Table 139. Gilead Science Company Information
Table 140. Gilead Science Introduction and Business Overview
Table 141. Gilead Science G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 142. Gilead Science G-CSF and G-CSF Biosimilars Product
Table 143. Gilead Science Recent Development
Table 144. GlaxoSmithKline Company Information
Table 145. GlaxoSmithKline Introduction and Business Overview
Table 146. GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 147. GlaxoSmithKline G-CSF and G-CSF Biosimilars Product
Table 148. GlaxoSmithKline Recent Development
Table 149. AbbVie Company Information
Table 150. AbbVie Introduction and Business Overview
Table 151. AbbVie G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 152. AbbVie G-CSF and G-CSF Biosimilars Product
Table 153. AbbVie Recent Development
Table 154. Amgen Company Information
Table 155. Amgen Introduction and Business Overview
Table 156. Amgen G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 157. Amgen G-CSF and G-CSF Biosimilars Product
Table 158. Amgen Recent Development
Table 159. AstraZeneca Company Information
Table 160. AstraZeneca Introduction and Business Overview
Table 161. AstraZeneca G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 162. AstraZeneca G-CSF and G-CSF Biosimilars Product
Table 163. AstraZeneca Recent Development
Table 164. Bayer Company Information
Table 165. Bayer Introduction and Business Overview
Table 166. Bayer G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 167. Bayer G-CSF and G-CSF Biosimilars Product
Table 168. Bayer Recent Development
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. G-CSF and G-CSF Biosimilars Market Trends
Table 172. G-CSF and G-CSF Biosimilars Market Drivers
Table 173. G-CSF and G-CSF Biosimilars Market Challenges
Table 174. G-CSF and G-CSF Biosimilars Market Restraints
Table 175. G-CSF and G-CSF Biosimilars Distributors List
Table 176. G-CSF and G-CSF Biosimilars Downstream Customers
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. G-CSF and G-CSF Biosimilars Product Picture
Figure 2. Global G-CSF and G-CSF Biosimilars Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global G-CSF and G-CSF Biosimilars Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global G-CSF and G-CSF Biosimilars Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Blood Disorders
Figure 6. Global Blood Disorders Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Oncology Diseases
Figure 8. Global Oncology Diseases Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Chronic And Autoimmune Diseases
Figure 10. Global Chronic And Autoimmune Diseases Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Growth Hormone Deficiencies
Figure 12. Global Growth Hormone Deficiencies Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Global G-CSF and G-CSF Biosimilars Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global G-CSF and G-CSF Biosimilars Sales Market Share by Type in 2022 & 2034
Figure 15. North America G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Type in 2022
Figure 16. North America G-CSF and G-CSF Biosimilars Sales Market Share in Value by Type in 2022
Figure 17. Europe G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Type in 2022
Figure 18. Europe G-CSF and G-CSF Biosimilars Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific G-CSF and G-CSF Biosimilars Sales Market Share in Value by Type in 2022
Figure 21. Latin America G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Type in 2022
Figure 22. Latin America G-CSF and G-CSF Biosimilars Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by G-CSF and G-CSF Biosimilars Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by G-CSF and G-CSF Biosimilars Revenue in 2022
Figure 27. G-CSF and G-CSF Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Human Growth Hormone
Figure 29. Global Human Growth Hormone Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Erythropoietin
Figure 31. Global Erythropoietin Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Monoclonal Antibodies
Figure 33. Global Monoclonal Antibodies Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Insulin
Figure 35. Global Insulin Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Product Picture of Interferon
Figure 37. Global Interferon Sales YoY Growth (2024-2034) & (K Units)
Figure 38. Global G-CSF and G-CSF Biosimilars Sales by Application (2024-2034) & (US$ Million)
Figure 39. Global G-CSF and G-CSF Biosimilars Sales Market Share by Application in 2022 & 2034
Figure 40. North America G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Application in 2022
Figure 41. North America G-CSF and G-CSF Biosimilars Sales Market Share in Value by Application in 2022
Figure 42. Europe G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Application in 2022
Figure 43. Europe G-CSF and G-CSF Biosimilars Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific G-CSF and G-CSF Biosimilars Sales Market Share in Value by Application in 2022
Figure 46. Latin America G-CSF and G-CSF Biosimilars Sales Market Share in Volume by Application in 2022
Figure 47. Latin America G-CSF and G-CSF Biosimilars Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. G-CSF and G-CSF Biosimilars Manufacturing Cost Structure
Figure 51. G-CSF and G-CSF Biosimilars Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries